289 related articles for article (PubMed ID: 34554178)
1. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
[TBL] [Abstract][Full Text] [Related]
2. Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes.
Xin T; Han H; Wu W; Huang X; Cui J; Matsubara JA; Song J; Wang F; Colyer M; Lei H
Exp Eye Res; 2020 Jan; 190():107884. PubMed ID: 31786159
[TBL] [Abstract][Full Text] [Related]
3. Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition.
Han H; Zhao X; Liao M; Song Y; You C; Dong X; Yang X; Wang X; Huang B; Du M; Yan H
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):29. PubMed ID: 34283209
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
[TBL] [Abstract][Full Text] [Related]
5. The role of thrombin in proliferative vitreoretinopathy.
Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
[TBL] [Abstract][Full Text] [Related]
6. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
[TBL] [Abstract][Full Text] [Related]
7. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
9. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
10. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
[TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.
Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M
PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.
Han H; Chen N; Huang X; Liu B; Tian J; Lei H
J Biol Chem; 2019 Oct; 294(42):15408-15417. PubMed ID: 31467081
[TBL] [Abstract][Full Text] [Related]
15. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
Commun Biol; 2019; 2():162. PubMed ID: 31069271
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
[TBL] [Abstract][Full Text] [Related]
17. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
[TBL] [Abstract][Full Text] [Related]
18. Role of macrophage migration inhibitory factor (MIF) in the effects of oxidative stress on human retinal pigment epithelial cells.
Ko JA; Sotani Y; Ibrahim DG; Kiuchi Y
Cell Biochem Funct; 2017 Oct; 35(7):426-432. PubMed ID: 28906008
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
Kirchhof B; Sorgente N
Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
